Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.

CS Pharmaceuticals snaps up AxeroVision to shore up ophthalmology portfolio – Pharmaceutical Technology

A sales forecast by GlobalData estimates that the 2028 dry eye disease drug market in the Asia-Pacific region will be worth $9.3bn. Image credit: Shutterstock/Minerva

August 2, 2023

Q&A: Talking Prior Authorization With Rep. Suzan DelBene

Although the Centers for Medicare & Medicaid Services (CMS) issued a final rule on prior authorization, there is more that can be done to ease

January 20, 2024

Eloxx moves ahead with plans with gene therapy for rare kidney disorder – Pharmaceutical Technology

Eloxx Pharmaceuticals is developing a therapy for the rare kidney disorder Alport syndrome. Credit: Ivan-balvan via Getty Images. US-based biotech Eloxx Pharmaceuticals announced the submission

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.